Raymond James & Associates’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-21,538
| Closed | -$669K | – | 3835 |
|
|
2022
Q2 | $669K | Buy |
21,538
+329
| +2% | +$10.2K | ﹤0.01% | 2713 |
|
|
2022
Q1 | $871K | Buy |
21,209
+4,258
| +25% | +$175K | ﹤0.01% | 2690 |
|
|
2021
Q4 | $737K | Sell |
16,951
-2,036
| -11% | -$88.5K | ﹤0.01% | 2814 |
|
|
2021
Q3 | $951K | Buy |
18,987
+1,331
| +8% | +$66.7K | ﹤0.01% | 2612 |
|
|
2021
Q2 | $1.11M | Sell |
17,656
-13,641
| -44% | -$859K | ﹤0.01% | 2513 |
|
|
2021
Q1 | $2.91M | Buy |
31,297
+11,081
| +55% | +$1.03M | ﹤0.01% | 1775 |
|
|
2020
Q4 | $1.81M | Buy |
20,216
+980
| +5% | +$87.8K | ﹤0.01% | 1941 |
|
|
2020
Q3 | $1.99M | Buy |
19,236
+2,247
| +13% | +$232K | ﹤0.01% | 1774 |
|
|
2020
Q2 | $1.34M | Buy |
16,989
+4,654
| +38% | +$368K | ﹤0.01% | 1956 |
|
|
2020
Q1 | $714K | Buy |
+12,335
| New | +$714K | ﹤0.01% | 2188 |
|
|
2019
Q4 | – | Sell |
-4,718
| Closed | -$247K | – | 3561 |
|
|
2019
Q3 | $247K | Buy |
+4,718
| New | +$247K | ﹤0.01% | 3104 |
|
|
2019
Q2 | – | Sell |
-9,081
| Closed | -$459K | – | 3541 |
|
|
2019
Q1 | $459K | Sell |
9,081
-2,074
| -19% | -$105K | ﹤0.01% | 2705 |
|
|
2018
Q4 | $661K | Buy |
11,155
+416
| +4% | +$24.7K | ﹤0.01% | 2350 |
|
|
2018
Q3 | $707K | Buy |
10,739
+317
| +3% | +$20.9K | ﹤0.01% | 2459 |
|
|
2018
Q2 | $526K | Sell |
10,422
-374
| -3% | -$18.9K | ﹤0.01% | 2642 |
|
|
2018
Q1 | $568K | Buy |
10,796
+3,136
| +41% | +$165K | ﹤0.01% | 2480 |
|
|
2017
Q4 | $356K | Hold |
7,660
| – | – | ﹤0.01% | 2729 |
|
|
2017
Q3 | $310K | Sell |
7,660
-414
| -5% | -$16.8K | ﹤0.01% | 2756 |
|
|
2017
Q2 | $274K | Buy |
8,074
+915
| +13% | +$31.1K | ﹤0.01% | 2761 |
|
|
2017
Q1 | $208K | Buy |
7,159
+135
| +2% | +$3.92K | ﹤0.01% | 2890 |
|
|
2016
Q4 | $231K | Buy |
7,024
+424
| +6% | +$13.9K | ﹤0.01% | 2784 |
|
|
2016
Q3 | $208K | Sell |
6,600
-1,856
| -22% | -$58.5K | ﹤0.01% | 2810 |
|
|
2016
Q2 | $238K | Buy |
8,456
+36
| +0.4% | +$1.01K | ﹤0.01% | 2541 |
|
|
2016
Q1 | $306K | Buy |
+8,420
| New | +$306K | ﹤0.01% | 2308 |
|